CFO Ching W. Jaw resigns effective Feb 23, 2024 for personal health reasons

CYTOKINETICS INC

SVP & CFO Ching W. Jaw resigns effective Feb 23, 2024, to attend to personal health condition.
Departure described as on mutually good terms between company and Mr. Jaw.
No successor named; company will need to appoint new CFO.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Ching W. Jaw

Senior Vice President & Chief Financial Officer

CYTK · CYTOKINETICS INC

Effective: 2024-02-23
Filed: February 2, 2024, 6:59 PM ET

On January 29, 2024, Ching W. Jaw, Senior Vice President & Chief Financial Officer, informed Cytokinetics, Incorporated (the "Company") that he would be resigning his office and employment with the Company effective February 23, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Ching W. Jaw resigned as Senior Vice President & Chief Financial Officer at CYTOKINETICS INC.

Action: resigned
Role: Senior Vice President & Chief Financial Officer

Exact text from the filing

On January 29, 2024, Ching W. Jaw, Senior Vice President & Chief Financial Officer, informed Cytokinetics, Incorporated (the "Company") that he would be resigning his office and employment with the Company effective February 23, 2024.

View on SEC.gov

CYTOKINETICS INC filing history →

Source: SEC EDGAR

accession 0000950170-24-010552

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.